Intrinsic
Screener
Valuation
Movers
Economy
Bonds
Institutions
Business Summaries
Updates
Go
Sign In
Screener
Summaries
Updates
Institutions
Sign In
More
↑
Overview
Financials
Chart
Business Summary
Filings
Ownership
Valuation
Alkermes plc.
(ALKS)
Pharmaceutical Preparations
Latest Price
$45.83
TTM P/E
120.61
Normalized P/E
55.08
Div Yield
--
Book Value
10.85
P/B Ratio
4.22
Valuation metrics
adjust assumptions →
EPS:
$1.43
Book value / share:
$10.99
Formula:
√(22.5 × EPS × BVPS)
Graham Number
$18.80
59% downside
Base FCF:
$379M (median of recent 5yr)
Growth:
18%/yr (median YOY, capped at 25%)
Discount rate:
10%
Terminal growth:
3%
Projection horizon:
10 years
DCF Fair Value
$107.41
+134% upside
EPS:
$1.43
Target P/E:
55×
Formula:
EPS × P/E
P/E Fair Value
$78.65
+72% upside
